ROP
108862
Approved small_molecule completed
Quick answer
ROP for Parkinson Disease is a Approved program (small_molecule) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Parkinson Disease
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed